Fatal adenovirus infection during alemtuzumab (anti-CD52 monoclonal antibody) treatment of a patient with fludarabine-refractory B-CELL chronic lymphocytic leukemia

By Cavalli-Björkman Nina   Ösby Eva   Lundin Jeanette   Kalin Mats   Österborg Anders   Gruber Astrid  

Medical Oncology, Vol. 19, Iss. 4, 2002-12 ,pp. : 277-280

Humana Press, Inc

Access to resources Recommend Favorite

Detection of CD133 expression in U87 glioblastoma cells using a novel anti-CD133 monoclonal antibody

By              

Oncology Letters, Vol. 9, Iss. 6, 2015-01 ,pp. : 2603-2608

Spandidos Publications

Access to resources Recommend Favorite

Preclinical Therapy of Breast Cancer with a Radioiodinated Humanized Anti-EGP-1 Monoclonal Antibody: Advantage of a Residualizing Iodine Radiolabel

By Govindan Serengulam V.   Stein Rhona   Qu Zhengxing   Chen Susan   Andrews Philip   Ma Hong   Hansen Hans J.   Griffiths Gary L.   Horak Ivan D.   Goldenberg David M.  

Breast Cancer Research and Treatment, Vol. 84, Iss. 2, 2004-03 ,pp. : 173-182

Springer Publishing Company

Access to resources Recommend Favorite

Combination therapy of gemcitabine or oral S-1 with the anti-VEGF monoclonal antibody bevacizumab for pancreatic neuroendocrine carcinoma

By                    

Experimental and Therapeutic Medicine, Vol. 3, Iss. 4, 2012-01 ,pp. : 599-602

Spandidos Publications

Access to resources Recommend Favorite

Functional inactivation of CD4+CD25 high regulatory T cells using low dose human/mouse chimeric anti-CD25 monoclonal antibody enhanced lymphokine-activated killer cells activity

By Okita Riki  

Targeted Oncology, Vol. 3, Iss. 4, 2008-10 ,pp. : 227-234

Springer Publishing Company

Access to resources Recommend Favorite